Your browser doesn't support javascript.
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit.
El Hajra, Ismael; Calvo, Marta; Santos Pérez, Elena; Blanco Rey, Santiago; González Partida, Irene; Matallana, Virginia; González-Lama, Yago; Vera, María Isabel.
  • El Hajra I; Aparato Digestivo, Hospital Universitario Puerta de Hierro, España.
  • Calvo M; Aparato Digestivo, Hospital Universitario Puerta de Hierro.
  • Santos Pérez E; Aparato Digestivo, Hospital Universitario Puerta de Hierro.
  • Blanco Rey S; Aparato Digestivo, Hospital Universitario Puerta de Hierro.
  • González Partida I; Aparato Digestivo, Hospital Universitario Puerta de Hierro.
  • Matallana V; Aparato Digestivo, Hospital Universitario Puerta de Hierro.
  • González-Lama Y; Aparato Digestivo, Hospital Universitario Puerta de Hierro, España.
  • Vera MI; Aparato Digestivo, Hospital Universitario Puerta de Hierro.
Rev Esp Enferm Dig ; 113(2): 98-102, 2021 02.
Article in English | MEDLINE | ID: covidwho-1068090
ABSTRACT

INTRODUCTION:

COVID-19 has altered the usual practice of medicine and the state of emergency declared in Spain on March 14th has considerably changed the activity of inflammatory bowel disease (IBD) units. The aim of this study was to evaluate the consequences of COVID-19 on the IBD Unit's activity and provide information on restructuring with available resources.

METHODS:

an observational study was performed in a referral hospital in Madrid (Spain). Type of appointment, loss of follow-up, hospital admission, treatment changes, endoscopic activity, surgeries and blood tests were evaluated between March 15th and May 15th, 2020. This data was compared with the usual activity a year before.

RESULTS:

among the 510 patients included, 476 (93.33 %) received had a remote consultation, representing an increase of 92.38 % compared with the previous year (0.95 %). There was a loss of follow-up in 26 patients (5.1 %) vs 15 (3.58 %) the previous year. A total of 60 (35.09 %) blood tests, 64 (76.19 %) endoscopies and all scheduled surgeries were suspended. Besides, 484 (94.9 %) patients remained adherent vs 417/419 (99.5 %) in the pre-pandemic period and 48 (9.41 %) reported symptoms of an IBD flare. Thirty-nine (7.6 %) patients developed symptoms suggestive of COVID-19.

CONCLUSION:

a large number of tests and on-site outpatient visit consultations were suspended. However, a rapid adaptation to telemedicine allowed these patients to be closely followed up. Although it was possible to maintain therapeutic compliance, with a loss to follow-up slightly higher than the previous year, suspensions and delays of tests could have significant negative consequences in the long term.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Rev Esp Enferm Dig Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Rev Esp Enferm Dig Journal subject: Gastroenterology Year: 2021 Document Type: Article